CheckMan Stock Market Overview

T. Rowe Price's (TROW) Q1 earnings beat estimates on increased net revenues, an improvement in AUM and a decline in expenses. A rise in cash and cash equivalents will help it continue investing.

Fair Isaac's (FICO) second-quarter fiscal 2024 results benefit from higher revenues from mortgage originations.

Colgate's (CL) Q1 results reflect balanced growth from volume and pricing, leading to top-line growth. Gross and operating profit margin expansions aid the bottom line.

A rise in revenues and an increase in asset position support Federated Hermes' (FHI) Q1 earnings. Higher operating costs act as headwinds.

Strong performance of SAPIEN 3 Ultra RESILIA platform and sustainable TAVR growth drives Edwards Lifesciences (EW) Q1 revenues.

Are things finally turning around for Nio (NYSE: NIO )? The Chinese electric vehicle (EV) producer has spent the past six months on a primarily downward trajectory.

Wall Street's enthusiasm for Nvidia (NASDAQ: NVDA ) isn't slowing down. The vast majority of analysts currently rate it as a “buy” and maintain bullish price targets.

ResMed easily beat Wall Street's earnings estimates for its fiscal Q3. The company's products are enjoying strong demand.

Automatic Data (ADP) third-quarter fiscal 2024 revenues are likely to have benefitted from growth in new bookings.

Agnico Eagle's (AEM) first-quarter earnings and revenues exceed expectations, driven by increased production and higher realized gold prices.